Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG V… is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by International Aids Vaccine Initative Inc. Estimated value $95.6M ($95.6M obligated). Current period of performance ends Dec 31, 2028. Last award drew 1 bidder. Place of performance: NEW YORK, NY. Related solicitation BAA18100SOL00003.
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN
Recompete timing
PublicCurrent PoP ends Dec 31, 2028 (826 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 1, 2027.
Want the durability read on 75A50121C00077? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordInternational Aids Vaccine Initative Inc — $29.2M obligated across 16 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50121C00077?
75A50121C00077 (Overall objective of THIS contract IS) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $95.6M, currently held by International Aids Vaccine Initative Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50121C00077?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50121C00077 to International Aids Vaccine Initative Inc.
Who is the incumbent on 75A50121C00077?
International Aids Vaccine Initative Inc is the incumbent with $29.2M across 16 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2028.
When does International Aids Vaccine Initative Inc’s 75A50121C00077 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75A50121C00077? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.